Global Psoriasis Treatment Market to Reach $12.8 Billion by 2025 - Promising Pipeline Molecules to Drive Growth - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report to their offering.

The Global Psoriasis Treatment Market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.

The psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is categorized on the basis of route of administration such as topical, oral and parenteral therapeutic drugs.

Currently, topical therapeutic drugs hold largest market share due to its safety, more effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would show significant growth during forecast period because newly approved biologics are generally preferred in moderate to severe psoriasis.

Companies Mentioned

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca
  • Biogen
  • Boehringer Ingelheim
  • Celgene
  • Eli Lilly and Company
  • Johnson & Johnson
  • LEO Pharma A/S
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Stiefel Laboratories Inc.
  • Sun Pharmaceutical Industries

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Psoriasis Treatment Market Analysis

Chapter 4 Global Psoriasis Treatment Market, by Drug Class

Chapter 5 Global Psoriasis Treatment Market, by Route of Administration

Chapter 6 Global Psoriasis Treatment Market, by Geography

Chapter 7 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/wnpcpw/global_psoriasis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Psoriasis Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Psoriasis Drugs